Expiring federal contract · order under a contract vehicle
W81K0026FA029 — Ino Therapeutics LLC
Department of Defense · Department of the Army
- Contract / PIID
- W81K0026FA029
- Incumbent
- Ino Therapeutics LLC
- Incumbent UEI
- XXQHL619FUN6
- Current end date
- December 31, 2026
- Potential total value
- $158,312
- Obligated
- $158,312
- NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- PSC
- 6505 — DRUGS AND BIOLOGICALS
- Set-aside
- Not stated
- Start date
- January 1, 2026
- Place of performance
- TX
- Award type
- DELIVERY ORDER
Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.
What the contract covers
INHALED NITRIC OXIDE
Likely rebid window (estimate)
- Sources Sought / RFI: about Dec 2025 – Jun 2026 (6–12 months before the end date)
- RFP: about Aug 2026 – Oct 2026 (2–4 months before the end date)
In the final months before the current end date.
This is an order under contract vehicle V797D60737. Orders are usually not competed on their own: the next order may be placed under the same vehicle.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Defense (NAICS 325412)
- HT001426FE010 — Cardinal Health 414, LLC · ends November 28, 2026 · $250K
- W81K0226PA002 — Value Drug, Limited · ends November 30, 2026 · $236K
- HT001426FE014 — Sofie CO. · ends January 14, 2027 · $250K
- HT001426FE016 — Central Admixture Pharmacy Services, INC · ends January 15, 2027 · $200K
- W81K0226FA029 — Jubilant Draximage Radiopharmacies, INC. · ends January 29, 2027 · $157K
- W91YTZ25CA004 — Lantheus Medical Imaging, INC. · ends February 2, 2027 · $693K
- HT001422P0039 — Sun Pharmaceutical Industries, INC. · ends March 10, 2027 · $967K
- HT940626FE037 — Cardinal Health 414, LLC · ends March 31, 2027 · $250K
- HT941025P0083 — Cardinal Health 414, LLC · ends March 31, 2027 · $450K
- W91YTZ23P0019 — B. Braun Medical INC · ends March 31, 2027 · $103K